Long Peripheral Intravenous Catheter Insertion Site and Catheter-related Complications in Antimicrobial Therapy

Launched by SIR RUN RUN SHAW HOSPITAL · Jun 6, 2024

Keywords

ClinConnect Summary

This clinical trial is studying the use of long peripheral intravenous catheters (PIVCs) in patients who are receiving antimicrobial therapy, which is a type of treatment to fight infections. The researchers want to find out if the placement of these catheters in different locations on the body affects complications, such as discomfort or infections. The goal is to help patients choose the best site for catheter placement, which could lead to fewer problems and a more comfortable experience during their treatment.

To participate in this study, you need to be at least 18 years old and expected to receive intravenous (IV) treatments for at least a week while in the hospital. You should be able to communicate normally and have no previous issues at the catheter insertion site, like trauma or blood clots. If you join the trial, you will have the catheter placed, and researchers will monitor your experience to help improve care for future patients. This study is currently recruiting participants, and anyone interested should consult with their healthcare provider for more information.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • ① estimated time of intravenous infusion ≥1 week; ② age: ≥18 years; ③ antimicrobial therapy was only used for treatment during hospitalization, with a pH value of 5-9 and osmotic pressure \< 900 mOsm/L; and ④ patients were conscious and able to communicate normally; ⑤ the catheter-to-vessel ratio is less than 45%.
• Exclusion Criteria:
• • ① a history of radiotherapy, thrombosis, and trauma at the catheterization site and ② plans to discharge with a catheter during the study duration.